Hoitt Jason
Stoke Therapeutics, Inc. · Chief Patient Officer
Hoitt Jason is listed in filings as Chief Patient Officer at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK). The current snapshot covers public activity from Feb 19, 2026 to Mar 19, 2026. Reported amounts are shown as $4.4K to $55.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $4.4k139 shares | SellMar 18, 2026 | $31.79 | $29.11 | |
| $98630 shares | SellMar 18, 2026 | $32.85 | $29.11 | |
| $55k1.8k shares | SellMar 18, 2026 | $31.28 | $29.11 |